These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 10637962

  • 21. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M, Olczak S.
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [Abstract] [Full Text] [Related]

  • 22. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G, Giovanni P.
    J Nephrol; 2002 Jun; 15(5):480-8. PubMed ID: 12455713
    [Abstract] [Full Text] [Related]

  • 23. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E, Wollheim FA.
    Lakartidningen; 2000 Jun 14; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P, van der Bijl P.
    Int J Immunopathol Pharmacol; 2003 Jun 14; 16(2 Suppl):17-22. PubMed ID: 14552700
    [Abstract] [Full Text] [Related]

  • 25. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G, Cravero E.
    Clin Ter; 2003 Jun 14; 154(1):39-43. PubMed ID: 12854282
    [Abstract] [Full Text] [Related]

  • 26. Defining COX-2 inhibitors.
    Lipsky PE.
    J Rheumatol Suppl; 2000 Oct 14; 60():13-6. PubMed ID: 11032097
    [Abstract] [Full Text] [Related]

  • 27. [New nonsteroidal antirheumatic drugs].
    Forster A, Michel BA.
    Praxis (Bern 1994); 2000 May 11; 89(20):855-60. PubMed ID: 10865508
    [No Abstract] [Full Text] [Related]

  • 28. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D, Gottlieb S, Godbourt U, Hod H, Kaluski E.
    Harefuah; 2002 Oct 11; 141(10):922-4. PubMed ID: 12420602
    [No Abstract] [Full Text] [Related]

  • 29. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.
    Rheumatology (Oxford); 2005 Jul 11; 44(7):921-4. PubMed ID: 15827035
    [Abstract] [Full Text] [Related]

  • 30. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part II. Side effects].
    Burdan F, Korobowicz A.
    Pol Merkur Lekarski; 2003 Apr 11; 14(82):352-5. PubMed ID: 12868201
    [Abstract] [Full Text] [Related]

  • 31. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA.
    J Am Osteopath Assoc; 1999 Nov 11; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [Abstract] [Full Text] [Related]

  • 32. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S, Crofford LJ.
    Bull Rheum Dis; 2001 Nov 11; 50(1):1-4. PubMed ID: 12092091
    [No Abstract] [Full Text] [Related]

  • 33. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 11; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [Abstract] [Full Text] [Related]

  • 34. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D.
    MMW Fortschr Med; 2000 Jan 20; 142(3):10. PubMed ID: 10726454
    [No Abstract] [Full Text] [Related]

  • 35. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V, Hutchins B.
    Dent Today; 2001 Feb 20; 20(2):56-61. PubMed ID: 12524847
    [No Abstract] [Full Text] [Related]

  • 36. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F, Michaud K, Burke TA, Zhao SZ.
    J Rheumatol; 2004 Feb 20; 31(2):355-8. PubMed ID: 14760808
    [Abstract] [Full Text] [Related]

  • 37. COX-2 inhibitors. What is their place?
    McGettigan P.
    Aust Fam Physician; 2000 Sep 20; 29(9):847-52. PubMed ID: 11008387
    [Abstract] [Full Text] [Related]

  • 38. The multisystem adverse effects of NSAID therapy.
    James DS.
    J Am Osteopath Assoc; 1999 Nov 20; 99(11 Suppl):S1-7. PubMed ID: 10643174
    [Abstract] [Full Text] [Related]

  • 39. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L, Hritz I, Molnar B, Herszenyi L, Tulassay Z.
    Int J Immunopathol Pharmacol; 2003 Nov 20; 16(2 Suppl):23-30. PubMed ID: 14552701
    [Abstract] [Full Text] [Related]

  • 40. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb 20; 25(4):4. PubMed ID: 10637015
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.